A better understanding of the role of activin-A/FSTL3 signaling in lung fibrosis may lay the foundations for new therapeutic approaches to the treatment and prevention of airway remodeling in asthma and other bronchopulmonary diseases. Here, FSTL3 is linked to pulmonary fibrosis.